Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Morotti

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Gynecologic Oncology|June 11, 2019
Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancerRoberto Tozzi, Jvan Casarin, Ahmet Baysal, et al.
Journal of Gynecologic Oncology|February 12, 2019
Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancerRoberto Tozzi, Jvan Casarin, Ahmet Baysal, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 26, 2011
Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnanciesMatteo Morotti, Silvia Podestà, Yuri Musizzano, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Patient-reported outcomes in adoptive cell-therapy trials: mind the gapEleonora Ghisoni, Matteo Morotti, Sara Colomer-Lahiguera, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 7, 2019
The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian CancerCiro Pinelli, Matteo Morotti, Jvan Casarin, et al.
Nature Reviews. Clinical Oncology|September 4, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approachEleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2013
Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancerMatteo Morotti, Mario Valenzano Menada, Francesco Boccardo, et al.
Methods and Protocols|August 6, 2020
Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic DeletionsJoseph Blayney, Evangeline M Foster, Marta Jagielowicz, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 7, 2017
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosisMatteo Morotti, Pier Luigi Venturini, Ennio Biscaldi, et al.
Journal of Minimally Invasive Gynecology|March 5, 2018
Concomitant Laparoscopic and Thoracoscopic Resection of Recurrent High-Grade Ovarian CancerRoberto Tozzi, Jvan Casarin, Elizabeth Belcher, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Gynecologic Oncology|June 11, 2019
Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancerRoberto Tozzi, Jvan Casarin, Ahmet Baysal, et al.
Journal of Gynecologic Oncology|February 12, 2019
Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancerRoberto Tozzi, Jvan Casarin, Ahmet Baysal, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 26, 2011
Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnanciesMatteo Morotti, Silvia Podestà, Yuri Musizzano, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Patient-reported outcomes in adoptive cell-therapy trials: mind the gapEleonora Ghisoni, Matteo Morotti, Sara Colomer-Lahiguera, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 7, 2019
The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian CancerCiro Pinelli, Matteo Morotti, Jvan Casarin, et al.
Nature Reviews. Clinical Oncology|September 4, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approachEleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2013
Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancerMatteo Morotti, Mario Valenzano Menada, Francesco Boccardo, et al.
Methods and Protocols|August 6, 2020
Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic DeletionsJoseph Blayney, Evangeline M Foster, Marta Jagielowicz, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 7, 2017
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosisMatteo Morotti, Pier Luigi Venturini, Ennio Biscaldi, et al.
Journal of Minimally Invasive Gynecology|March 5, 2018
Concomitant Laparoscopic and Thoracoscopic Resection of Recurrent High-Grade Ovarian CancerRoberto Tozzi, Jvan Casarin, Elizabeth Belcher, et al.
Pageof 6